Oscar Health (NYSE:OSCR – Get Free Report) is expected to be announcing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Oscar Health to post earnings of $0.4026 per share and revenue of $4.7301 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:00 AM ET.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same period in the previous year, the business earned $0.92 EPS. The company’s quarterly revenue was up 52.6% compared to the same quarter last year. On average, analysts expect Oscar Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Oscar Health Trading Down 1.1%
Shares of OSCR opened at $30.40 on Wednesday. Oscar Health has a fifty-two week low of $10.69 and a fifty-two week high of $33.10. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The company’s fifty day moving average is $28.57 and its 200 day moving average is $20.16. The stock has a market capitalization of $9.16 billion, a PE ratio of -51.52, a P/E/G ratio of 1.61 and a beta of 2.36.
Insider Activity at Oscar Health
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Focus Partners Wealth boosted its stake in shares of Oscar Health by 1.4% during the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares in the last quarter. Equitable Holdings Inc. boosted its position in Oscar Health by 7.0% during the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after acquiring an additional 850 shares in the last quarter. Captrust Financial Advisors increased its holdings in shares of Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after acquiring an additional 895 shares during the period. O Shaughnessy Asset Management LLC raised its position in shares of Oscar Health by 5.6% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock worth $255,000 after acquiring an additional 938 shares in the last quarter. Finally, Binnacle Investments Inc lifted its stake in shares of Oscar Health by 28.6% during the 3rd quarter. Binnacle Investments Inc now owns 4,500 shares of the company’s stock worth $85,000 after purchasing an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on OSCR shares. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and raised their price target for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Weiss Ratings upgraded shares of Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. Finally, Barclays raised shares of Oscar Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $30.00 to $35.00 in a research report on Wednesday, June 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $22.00.
Check Out Our Latest Stock Report on OSCR
About Oscar Health
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Recommended Stories
- Five stocks we like better than Oscar Health
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
